Leesburg, Va.-based K2M continues to make a splash in the spine market, according to Seeking Alpha.
Here are four insights:
1. K2M has positioned itself as a strong competitor in the complex spinal deformity market.
2. The company has disrupted the scoliosis market, offering products that are less invasive and more convenient.
3. In 2015, K2M received 15 FDA approvals and launched numerous new products including Cascade, Everest, Mesa 2 and Capri corpectomy cages.
4. Although the company's shares seem undervalued, K2M is small and the new products may drive growth in 2016.